Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GABAPENTIN ENACARBIL: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

61.5%
Female
38.5%
Male

Age Information

The average age of patients reporting adverse events with GABAPENTIN ENACARBIL is 54.6 years.

Geographic Distribution

The majority of adverse event reports for GABAPENTIN ENACARBIL originate from US.

Report Summary & Outcomes

1,833
Total Reports
1,833
As Primary/Secondary Suspect
649
Deaths Reported
237
Hospitalizations
26
Life-Threatening
32
Disabilities

Reporting Timeline

First adverse event report: 2009. Most recent report: 20250415. View full timeline →

More About GABAPENTIN ENACARBIL

GABAPENTIN ENACARBIL Full Profile Reports by Year Drug Interactions